期刊文献+

微小RNA-194对基底样乳腺癌细胞HCC1937增殖、迁移侵袭及上皮-间充质转化的影响 被引量:3

Effects of microRNA-194 on proliferation, migration, invasion and epithelial-mesenchymal transition of basal-like breast cancer cell line HCC1937
原文传递
导出
摘要 目的 观察微小RNA-194(miR-194)对人基底样乳腺癌细胞(HCC1937)增殖、迁移侵袭能力及上皮-间充质转化(E MT)的影响.方法 利用慢病毒作载体(MOI=50)携带miR-194感染基底样乳腺癌细胞HCC1937为实验组,携带CON157慢病毒感染乳腺癌细胞HCC1937为阴性对照组,未做处理的HCC1937细胞为空白对照组.细胞计数试剂盒(CCK-8)法与Transwell小室实验分别检测HCC1937细胞增殖、迁移侵袭能力;Western blot方法检测EMT相关蛋白E-钙黏蛋白(E-cadherin)、N-钙黏蛋白(N-cadherin)的表达.结果 实验组细胞增殖能力为(44.81±0.11)%,显著低于阴性对照组为(104.29 ±0.13)%,空白对照组为(100±0)%(P <0.01);实验组细胞迁移及侵袭力显著低于阴性对照组及空白对照组(P<0.05);E-cadherin蛋白:实验组(0.175 ±0.053)显著低于阴性对照组(0.516 ±0.032)、空白对照组(0.433±0.047,P<0.05);N-cadherin蛋白表达实验组(0.342±0.012)显著低于阴性对照组(0.137 ±0.007)、空白对照组(0.142 ±0.021,P<0.01).结论 miR-194能抑制基底细胞样乳腺癌细胞HCC1937增殖、迁移侵袭能力及EMT. Objective To explore the role of microRNA-194 (miR-194) in proliferation,migration,invasion and the epithelial-mesenchymal transition (EMT) of human basal-like breast cancer cell line HCC1937.Methods Three groups were set up:experimental group [HCC1937 with lentivirus-miR-194-enhanced green fluorescent protein (EGFP),MOI =50],negative control group (HCC1937with lentivirus-CON157-EGFP),and blank control group (HCC1937 without lentivirus).The miR-194 expression was detected by real-time quantitative reverse transcriptase-polymerase chain reaction (RT-qPCR).Cell growth ability of HCC1937 was determined by cell counting kit-8 (CCK-8) assay.Cell migration and invasion ability of HCC1937 were mearsured by a Transwell assay,and the protein of epithelial-mesenchymal transition phenotype was measured by Western blotting.Results The expression of miR-194 in experimental group (432.93 ± 0.01) was higher than in negative control group (0.90 ±0.02) and blank control group (1) (P 〈0.01) The cells in experimental group grew more slowly [(44.81 ± 0.11)%] than negative control group [(104.29 ± 0.13)%] and blank control group [(100 ±0) %,P 〈0.01].The number of migration and invasion was both less in experimental group than in negative control group and blank control group (P 〈 0.05).Western blotting revealed that the expression of E-cadherin in experimental group (0.175 ± 0.053) was significantly decreased as compared with negative control group (0.516 ± 0.032) and blank control group (0.433 ± 0.047,P 〈 0.05),and the expression of N-cadherin in experimental group (0.342 ± 0.012) was significantly increased as compared with negative control group (0.137 ±0.007) and blank control group (0.142 ±0.021) (P 〈0.05).Conclusion miR-194 can inhibit proliferation,migration and invasion of basal-like breast cancer cells (HCC1937),and also affect EMT process in HCC1937 cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第5期969-972,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金青年科学基金资助项目(81302290) 山东省自然科学基金资助项目(ZR2013HM019)
关键词 基底细胞样乳腺癌 微小RNA-194 增殖 Basal - like breast cancer MicroRNA - 194 Proliferation
  • 相关文献

参考文献7

  • 1潘红,凌立君,周文斌,梁秀清,王水.小干扰RNA下调Notch-1基因的表达对三阴性乳腺癌MDA—MB-231细胞生物学功能的影响[J].中华实验外科杂志,2012,29(5):797-800. 被引量:5
  • 2Song Y, Zhao F, Wang Z, et aL Inverse association between miR-194 expression arid tumor invasion in gastric cancer[ J]. Ann Surg Oncol, 2012,19(3) :509-517.
  • 3Dong P, Kaneuehi M, Watari H, et al. MieroRNA-194 inhibits epitheli- al to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-I [ J ]. Mol Cancer,2011,10:99.
  • 4王浩,顾劲扬,丁义涛.上皮-间充质转化调控的分子机制研究进展[J].中华实验外科杂志,2014,31(1):221-222. 被引量:7
  • 5Pavelic SK, Sedic M, Bosnjak H, et al. Metastasis. new perspectives on an old problem[ J ]. Mol Cancer,2011,10:22.
  • 6Li Z, Ying X, Chen H, et al. MicroRNA-194 inhibits the epithelial- mesenchymal transition in gastric cancer cells by targeting FoxMl [ J]. Dig Dis Sci,2014,59(9) :2145-2152.
  • 7Meng Z,Fu X,Chen X,et al. MiR-194 is a marker of hepatic epitheli- al cells and suppresses metastasis of liver cancer cells in mice [ J ]. Hepatology ,2010,52 (6) :2148-2157.

二级参考文献46

  • 1孙慧,战忠利.凋亡抑制蛋白bcl-2/bax基因活性水平在乳腺癌发展中的调节作用[J].中华实验外科杂志,2004,21(10):1264-1264. 被引量:3
  • 2Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res ,2006 ,66 :1517-1525.
  • 3Miele L. Rational targeting of Notch signaling in breast cancer. Expert Rev Anticancer Ther,2008,8 : 1197-1202.
  • 4Gidzinska B. Notch1 receptor: structure and role during T-cell development. Postepy Hig Med Dosw ,2003,57:369-376.
  • 5Reedijk M, Odoreic S, Chang L, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res ,2005,65:8530-8537.
  • 6Reedijk M, Pinnaduwage D, Dickson BC, et al. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat ,2008,111:439-448.
  • 7Dickson BC, Mulligan AM, Zhang H, et al. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod Patho1,2007, 20:685 -693.
  • 8Oswald F, Liptay S, Adler G, et al. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol, 1998,18: 2077 -2088.
  • 9Dent R,Trudean M, Pritchard KI, et al. Triple negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 2007, 13:4429-4434.
  • 10Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res,2006,66:1517-1525.

共引文献10

同被引文献10

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部